Stelara and Renal mass - a phase IV clinical study of FDA data
Summary:
Renal mass is reported as a side effect among people who take Stelara (ustekinumab), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months and have Ankylosing spondylitis.
The phase IV clinical study analyzes which people have Renal mass when taking Stelara. It is created by eHealthMe based on reports of 95,658 people who have side effects when taking Stelara from the FDA, and is updated regularly.
What is Stelara?
Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.
What is Renal mass?
Renal mass (mass in kidney) is found to be associated with 429 drugs and 400 conditions by eHealthMe. Check the latest studies of Renal mass.
95,658 people reported to have side effects when taking Stelara.
Among them, 18 people (0.02%) have Renal mass.

Among these 18 people:
How long have people been on Stelara when they have Renal mass? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 50 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Renal mass when taking Stelara? *
- female: 11.76 %
- male: 88.24 %
What is the age of people who have Renal mass when taking Stelara? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 16.67 %
- 50-59: 33.33 %
- 60+: 50.0 %
What are other side effects people have besides Renal mass? *
- Fatigue (feeling of tiredness): 4 people, 22.22%
- Pain: 3 people, 16.67%
- Hyperhidrosis (abnormally increased sweating): 2 people, 11.11%
- Cardiac Failure Congestive: 2 people, 11.11%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
- Kidney Infection: 2 people, 11.11%
- Insomnia (sleeplessness): 2 people, 11.11%
- Cachexia (loss of weight): 2 people, 11.11%
- Thrombocytosis: 2 people, 11.11%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 11.11%
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Stelara and have Renal mass?
- Check whether Renal mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Stelara:
- Stelara (96,053 reports)
Renal mass treatments and more:
- Renal mass (2,774 reports)
How severe was Renal mass and when was it recovered:
Expand to all the drugs that have ingredients of ustekinumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Stelara:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Renal mass:
- Renal mass (429 drugs)
Browse all the conditions that are associated with Renal mass:
- Renal mass (400 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ustekinumab (the active ingredients of Stelara) and Stelara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ursodiol cause Primary Pulmonary Hypertension? - 23 seconds ago
- Could Clopidogrel cause Bradycardia? - 41 seconds ago
- Drug interactions of Calcium Carbonate and Pred Forte - 43 seconds ago
- Drug interactions of Calcium Carbonate and Ceftriaxone Sodium - 50 seconds ago
- Drug interactions of Azelastine Hydrochloride and Calcium Carbonate - 57 seconds ago
- Drug interactions of Myrbetriq and Aleve - a minute ago
- Drug interactions of Phytomenadione and Sodium Bicarbonate - a minute ago
- Drug interactions of Meropenem and Fluorometholone - 2 minutes ago
- Drug interactions of Topamax and Xarelto - 2 minutes ago
- Immunodeficiency Disorders and Rash Erythematous - 2 minutes ago